Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU mergers and takeovers (Jan 28)

Wed, 28th Jan 2015 18:21

BRUSSELS, Jan 28 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- Generic drugmaker Mylan Inc to purchase AbbotLaboratories' specialty and branded generics businessoutside the United States (approved Jan. 28)

-- Swiss drugmaker Novartis to acquire Britishpeer GlaxoSmithKline's oncology products (approved Jan.28)

-- British drugmaker GlaxoSmithKline to acquireNovartis' vaccines business, excluding flu, and thesetting up of a consumer healthcare joint venture (approved Jan.28)

NEW LISTINGS

None

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

JAN 28

-- French chemicals producer Arkema to purchaseBlu-Tack maker Bostik from French oil major Total (notified Dec. 12/deadline Jan. 28)

FEB 5

-- Belgian telecoms group Telenet to acquire 50percent stake in Belgian broadcasting company De Vijver Media(notified Aug. 18/deadline extended for the second time to March5 from Feb. 5)

FEB 9

-- Proposed joint venture for 1 gigawatt "Nemo" power linkbetween Belgium and Britain between Britain's National Grid and Belgium's transmission system operator Elia (notified Jan. 5/deadline Feb. 9/simplified)

FEB 12

-- European private equity firm CVC Capital Partners to buy Finnish insulation material maker Paroc for enterprise value of some 700 million euros.(notified Jan. 8/deadline Feb. 12)

FEB 13

-- German conglomerate Siemens to purchase U.S.oilfield equipment maker Dresser-Rand Group Inc (notified Jan. 9/deadline Feb. 13)

-- Japanese building materials and housing equipment groupLIXIL Group Corp to take sole control of sanitoryfittings group Grohe (notified Jan. 9/deadline Feb13/simplified)

FEB 16

-- Private equity firm Bain Capital to acquire Britishbrickmaker Ibstock Group from Irish buidling supplies group CRH (notified Jan. 12/deadline Feb. 16/simplified)

FEB 17

-- Private equity firm Apax Partners to acquire ScandinavianIT services provider Evry (notified Jan. 13/deadline Feb.17/simplified)

FEB 18

-- Canadian asset manager Brookfield Infrastructure Fund to acquire broadcasting and wireless telecominfrastructure platform operator TDF S.A.S.(notified Jan.14/deadline Feb. 18/simplified)

FEB 19

-- Swiss telecoms provider Swisscom and carleasing company Sixt to set up a joint venture (notified Jan.15/deadline Feb. 19/simplified)

FEB 20

-- French minerals company Imerys to acquire rivalS&B Minerals (notified Jan. 15/deadline Feb. 20)

FEB 23

-- U.S. conglomerate General Electric to acquire mostof French engineering group Alstom's power equipmentbusiness (notified Jan. 19/deadline Feb. 23)

-- Commodities trader Cargill to buy rival ArcherDaniels Midland Co's global chocolate business (notifiedJan. 19/deadline Feb. 23)

-- German DIY retailer OBI to acquire a joint venture led byBrico Business Cooperation (notified Jan. 19/deadline Feb.23/simplified)

FEB 25

-- Asset manager The Carlyle Group and private equityfirm Warburg Pincus to jointly acquire control of creditrating agency DBRS Holdings (notified Jan. 21/deadline Feb.25/simplified)

FEB 26

-- German car parts maker ZF Friedrichshafen to buyU.S. peer TRW Automotive Holdings Corp (notified Jan.22/deadline Feb. 26)

FEB 27

-- Canadian private equity firm Onex Corp toacquire aseptic filler machines maker SIG Combibloc Group AG and SIG Holding USA (notified Jan. 23/deadline Feb.27/simplified)

MARCH 5

-- Belgian telecoms group Telenet, which is asubsidiary of U.S. cable group Liberty Global, toacquire 50 percent stake in Belgian broadcasting company DeVijver Media (notified Aug. 18/deadline extended for the secondtime to March 5 from Feb. 5/companies submitted concessions onNov. 24)

APRIL 22

-- SOCAR, Azerbaijan's state energy company, to buy stakesin Greek natural gas grid operator DESFA from Greek natural gasutility DEPA (notified Oct. 1/deadline extended for the secondtime to April 22 from March 23)

APRIL 30

-- French telecoms operator Orange to acquireSpanish provider Jazztel (notified Oct. 16/deadlineextended to April 30 from April 24 after the Commission resumedits scrutiny after a four-day halt)

MAY 13

-- Mondelez International Inc and competitor D.EMaster Blenders to merge their coffee businesses innew company called Jacobs Douwe Egberts (notified Oct.27/deadline extended for the third time to May 13 from May 6)

MAY 29

-- PRS for Music Ltd (PRSfM), Foreningen Svenska TonsattaresInternationella Mysikbyra (Stim) and Gesellschaft fürmusikalische Aufführungs- und mechanischeVervielfältigungsrechte (Gema) to set up a joint venture toadminister mechanical and performing rights (notified Nov.28/deadline extended to May 29 from Jan. 14 after the Commissionopened an in-depth probe)

SUSPENDED

-- U.S. orthopaedic products maker Zimmer Holdings to acquire rival Biomet Inc (notified Aug.29/deadline suspended from Dec. 2, 2014)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified - that is, ordinary first-stage reviews - untilthey are approved. (Editing by Foo Yun Chee)

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.